ACADIA PHARMACEUTICALS INC. Increase (Decrease) in Deferred Revenue
ACADIA PHARMACEUTICALS INC. (ACAD) reported Increase (Decrease) in Deferred Revenue of -$2.64 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-27.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2018-11-06
- ACADIA PHARMACEUTICALS INC. increase (decrease) in deferred revenue for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- ACADIA PHARMACEUTICALS INC. increase (decrease) in deferred revenue for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
- ACADIA PHARMACEUTICALS INC. increase (decrease) in deferred revenue for the quarter ending 2017-06-30 was -$4.13M.
- ACADIA PHARMACEUTICALS INC. increase (decrease) in deferred revenue for the quarter ending 2017-03-31 was $1.49M.
- ACADIA PHARMACEUTICALS INC. increase (decrease) in deferred revenue for fiscal 2017 was -$2.64M, a 200.00% decline from fiscal 2016.
- ACADIA PHARMACEUTICALS INC. increase (decrease) in deferred revenue for fiscal 2016 was $2.64M.
- ACADIA PHARMACEUTICALS INC. increase (decrease) in deferred revenue for fiscal 2014 was -$55.00K.
- ACADIA PHARMACEUTICALS INC. increase (decrease) in deferred revenue for fiscal 2013 was -$379.00K.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $0.00 derived: sum of 2 quarters · filed 2018-11-06 | -$4.13M derived: sum of 3 quarters · filed 2018-11-06 | -$2.64M 10-K · filed 2018-02-27 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$4.13M derived: sum of 2 quarters · filed 2018-11-06 | -$2.64M 10-Q · filed 2018-11-06 | -$1.88M derived: sum of 4 quarters · filed 2018-11-06 |
| 2017-06-30 | -$4.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$2.64M 10-Q · filed 2018-08-08 | -$1.88M derived: sum of 3 quarters · filed 2018-08-08 | -$513.00K derived: sum of 4 quarters · filed 2018-08-08 |
| 2017-03-31 | $1.49M 10-Q · filed 2018-05-04 | $2.26M derived: sum of 2 quarters · filed 2018-05-04 | $3.62M derived: sum of 3 quarters · filed 2018-05-04 | |
| 2016-12-31 | $768.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $2.13M derived: sum of 2 quarters · filed 2018-02-27 | $2.64M 10-K · filed 2018-02-27 | |
| 2016-09-30 | $1.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $1.88M 10-Q · filed 2017-11-07 | ||
| 2016-06-30 | $513.00K 10-Q · filed 2017-08-08 | |||
| 2014-12-31 | -$15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | -$29.00K derived: sum of 2 quarters · filed 2017-02-28 | -$42.00K derived: sum of 3 quarters · filed 2017-02-28 | -$55.00K 10-K · filed 2017-02-28 |
| 2014-09-30 | -$14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$27.00K derived: sum of 2 quarters · filed 2015-11-05 | -$40.00K 10-Q · filed 2015-11-05 | -$65.00K derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | -$13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$26.00K 10-Q · filed 2015-08-06 | -$51.00K derived: sum of 3 quarters · filed 2016-02-29 | -$82.00K derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | -$13.00K 10-Q · filed 2015-05-07 | -$38.00K derived: sum of 2 quarters · filed 2016-02-29 | -$69.00K derived: sum of 3 quarters · filed 2016-02-29 | -$98.00K derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | -$25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$56.00K derived: sum of 2 quarters · filed 2016-02-29 | -$85.00K derived: sum of 3 quarters · filed 2016-02-29 | -$379.00K 10-K · filed 2016-02-29 |
| 2013-09-30 | -$31.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$60.00K derived: sum of 2 quarters · filed 2014-11-10 | -$354.00K 10-Q · filed 2014-11-10 | -$186.00K derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-06-30 | -$29.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | -$323.00K 10-Q · filed 2014-08-05 | -$155.00K derived: sum of 3 quarters · filed 2015-02-26 | -$3.06M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-03-31 | -$294.00K 10-Q · filed 2014-05-06 | -$126.00K derived: sum of 2 quarters · filed 2015-02-26 | -$3.03M derived: sum of 3 quarters · filed 2015-02-26 | -$3.04M derived: sum of 4 quarters · filed 2015-02-26 |
| 2012-12-31 | $168.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | -$2.74M derived: sum of 2 quarters · filed 2015-02-26 | -$2.75M derived: sum of 3 quarters · filed 2015-02-26 | -$2.82M 10-K · filed 2015-02-26 |
| 2012-09-30 | -$2.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | -$2.92M derived: sum of 2 quarters · filed 2013-11-06 | -$2.99M 10-Q · filed 2013-11-06 | -$2.88M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-06-30 | -$13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | -$85.00K 10-Q · filed 2013-08-06 | $22.00K derived: sum of 3 quarters · filed 2014-02-27 | -$63.00K derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-03-31 | -$72.00K 10-Q · filed 2013-05-07 | $35.00K derived: sum of 2 quarters · filed 2014-02-27 | -$50.00K derived: sum of 3 quarters · filed 2014-02-27 | $174.00K derived: sum of 4 quarters · filed 2014-02-27 |
| 2011-12-31 | $107.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $22.00K derived: sum of 2 quarters · filed 2014-02-27 | $246.00K derived: sum of 3 quarters · filed 2014-02-27 | -$57.00K 10-K · filed 2014-02-27 |
| 2011-09-30 | -$85.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05 | $139.00K derived: sum of 2 quarters · filed 2012-11-05 | -$164.00K 10-Q · filed 2012-11-05 | -$26.13M derived: sum of 4 quarters · filed 2013-03-12 |
| 2011-06-30 | $224.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | -$79.00K 10-Q · filed 2012-08-08 | -$26.05M derived: sum of 3 quarters · filed 2013-03-12 | -$26.00M derived: sum of 4 quarters · filed 2013-03-12 |
| 2011-03-31 | -$303.00K 10-Q · filed 2012-05-08 | -$26.27M derived: sum of 2 quarters · filed 2013-03-12 | -$26.23M derived: sum of 3 quarters · filed 2013-03-12 | |
| 2010-12-31 | -$25.97M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | -$25.93M derived: sum of 2 quarters · filed 2013-03-12 | -$25.30M 10-K · filed 2013-03-12 | |
| 2010-09-30 | $43.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $666.00K 10-Q · filed 2011-11-09 | ||
| 2010-06-30 | $623.00K 10-Q · filed 2011-08-10 | |||
| 2009-12-31 | $28.18M 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |